Market Closed -
Hong Kong S.E.
01:38:22 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
1.02
HKD
|
+0.99%
|
|
+2.00%
|
-15.00%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
665.2
|
611.1
|
269.5
|
379.6
|
618.7
|
721.1
|
Enterprise Value (EV)
1 |
468.5
|
454.9
|
243.5
|
283.8
|
523.3
|
262.4
|
P/E ratio
|
27.6
x
|
22.5
x
|
-6.67
x
|
2.63
x
|
1.65
x
|
3.99
x
|
Yield
|
1.63%
|
1.86%
|
-
|
12%
|
18.4%
|
8.42%
|
Capitalization / Revenue
|
1.28
x
|
1.16
x
|
0.59
x
|
0.58
x
|
0.55
x
|
0.72
x
|
EV / Revenue
|
0.9
x
|
0.86
x
|
0.54
x
|
0.43
x
|
0.47
x
|
0.26
x
|
EV / EBITDA
|
9.65
x
|
9.46
x
|
-30.1
x
|
1.82
x
|
1.2
x
|
0.81
x
|
EV / FCF
|
14.9
x
|
12.2
x
|
12.5
x
|
18.6
x
|
3.6
x
|
0.5
x
|
FCF Yield
|
6.71%
|
8.22%
|
8.01%
|
5.37%
|
27.8%
|
201%
|
Price to Book
|
2.43
x
|
1.95
x
|
1.04
x
|
0.93
x
|
0.83
x
|
0.89
x
|
Nbr of stocks (in thousands)
|
3,61,502
|
3,79,552
|
3,79,552
|
3,79,552
|
3,79,552
|
3,79,552
|
Reference price
2 |
1.840
|
1.610
|
0.7100
|
1.000
|
1.630
|
1.900
|
Announcement Date
|
29/10/18
|
29/10/19
|
30/10/20
|
28/10/21
|
28/10/22
|
30/10/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
518
|
528.6
|
453.7
|
654.7
|
1,122
|
1,002
|
EBITDA
1 |
48.56
|
48.09
|
-8.087
|
155.8
|
437.6
|
323.5
|
EBIT
1 |
38.27
|
35.9
|
-18.59
|
146.1
|
428.8
|
307.1
|
Operating Margin
|
7.39%
|
6.79%
|
-4.1%
|
22.31%
|
38.23%
|
30.65%
|
Earnings before Tax (EBT)
1 |
31.79
|
34.72
|
-39.01
|
168.8
|
445.3
|
238.8
|
Net income
1 |
24.11
|
26.62
|
-40.37
|
144.5
|
375.3
|
180.8
|
Net margin
|
4.65%
|
5.04%
|
-8.9%
|
22.06%
|
33.46%
|
18.05%
|
EPS
2 |
0.0667
|
0.0717
|
-0.1064
|
0.3806
|
0.9888
|
0.4760
|
Free Cash Flow
1 |
31.44
|
37.41
|
19.5
|
15.24
|
145.5
|
528.3
|
FCF margin
|
6.07%
|
7.08%
|
4.3%
|
2.33%
|
12.97%
|
52.74%
|
FCF Conversion (EBITDA)
|
64.73%
|
77.79%
|
-
|
9.78%
|
33.25%
|
163.32%
|
FCF Conversion (Net income)
|
130.38%
|
140.5%
|
-
|
10.55%
|
38.77%
|
292.13%
|
Dividend per Share
2 |
0.0300
|
0.0300
|
-
|
0.1200
|
0.3000
|
0.1600
|
Announcement Date
|
29/10/18
|
29/10/19
|
30/10/20
|
28/10/21
|
28/10/22
|
30/10/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
197
|
156
|
26
|
95.8
|
95.4
|
459
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
31.4
|
37.4
|
19.5
|
15.2
|
146
|
528
|
ROE (net income / shareholders' equity)
|
8.73%
|
8.96%
|
-14.1%
|
43.2%
|
65.2%
|
23.3%
|
ROA (Net income/ Total Assets)
|
7.21%
|
5.97%
|
-2.78%
|
17.5%
|
30.3%
|
15.8%
|
Assets
1 |
334.5
|
446.2
|
1,454
|
823.1
|
1,240
|
1,141
|
Book Value Per Share
2 |
0.7600
|
0.8300
|
0.6800
|
1.080
|
1.950
|
2.130
|
Cash Flow per Share
2 |
0.5200
|
0.4200
|
0.3200
|
0.3800
|
0.7100
|
1.690
|
Capex
1 |
9.29
|
8.61
|
11.5
|
14.1
|
76.5
|
84
|
Capex / Sales
|
1.79%
|
1.63%
|
2.53%
|
2.15%
|
6.82%
|
8.39%
|
Announcement Date
|
29/10/18
|
29/10/19
|
30/10/20
|
28/10/21
|
28/10/22
|
30/10/23
|
|
1st Jan change
|
Capi.
|
---|
| -15.00% | 49.05M | | +19.99% | 84.31B | | -28.62% | 69.9B | | +9.65% | 29.06B | | -8.90% | 17.38B | | +2.35% | 17.01B | | +0.17% | 15.35B | | +6.78% | 12.91B | | +69.35% | 12.47B | | +7.27% | 12.26B |
Other Healthcare Facilities & Services
|